John Kirby, the White House national security spokesman, told reporters that China has not asked for help at this stage.
“We have made it known that we are ready to help them in any way they deem acceptable. That was true when the pandemic was raging, and it is true today,” Kirby told reporters.
White House National Security Advisor Jake Sullivan told reporters earlier this week that US and Chinese officials had discussed COVID-19 and that different countries’ responses to the pandemic had been discussed at state meetings. United States and China, but did not provide details.
“I want to give us the opportunity to have these conversations in sensitive diplomatic channels. And we’ll see what comes of it, if anything,” he said.
China Meheco Group Co Ltd said Wednesday it had signed an agreement with U.S. pharmaceutical maker Pfizer Inc to import and distribute its oral COVID-19 treatment Paxlovid in mainland China as the country prepares for an influx of patients after scaling back its “zero COVID” policy.
Pfizer already signed an agreement in August with Chinese pharmaceutical manufacturer Zhejiang Huahai < 600521.SS. produce Paxlovid in mainland China only for patients from that country.
China began to move away from a “zero COVID” policy just this month, after protests against the economy-damaging restrictions that had been backed by President Xi Jinping. The change has raised concerns about an increase in COVID cases.
